When you partner with us, our world-class scientists integrate with your team and bring unrivaled expertise advancing therapies. Schedule a 25 minute free consult to develop creative solutions to your drug discovery. https://okt.to/EyTx5Q #drugdiscovery
Discovery | Charles River
Biotechnology
Wilmington, MA 15,159 followers
Shouldn’t our next discovery be yours?
Über uns
Discovery from Charles River is industry-proven in the successful development of potential novel therapies, with over 100 preclinical drug candidates and over 420 patents delivered to our sponsors. Backed by more than 1,100 scientists, our comprehensive, multi-modality integrated portfolio employs the latest technology and platforms to provide chemistry, biology, pharmacology and toxicology services that support clients from the earliest stages of target discovery through IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.
- Website
-
https://www.criver.com/products-services/discovery-services
External link for Discovery | Charles River
- Industrie
- Biotechnology
- Größe des Unternehmens
- 10.001+ Mitarbeiter
- Hauptsitz
- Wilmington, MA
Aktualisierungen
-
Logica makes it possible to scan a broader universe of available chemistry, accelerating your process with leading-edge technology. Our #AI integration enables rapid iteration of billions of virtual molecules, allowing you to rank and deliver novel chemistries more quickly and efficiently. See what sets our platform apart on our website. https://okt.to/lUPMHL #AI #Logica #Drugdiscovery #LogicaAI
-
85% of drugs approved by the FDA in 2023 were developed with Charles River. Connect with our experts at #BostonDOT24 (booth #306) to explore how you can move confidently from concept to candidate: https://okt.to/EUkqTX
-
Learn about the bispecific #antibody discovery process in a new case study using four bispecific formats. Download the poster: https://okt.to/YeAOtx
-
How is the application of machine learning to Cryo-EM filling a capability gap in lipid nanoparticle research? Listen now to find out: https://okt.to/KvULG5
-
Unlock the transformative power of #AI in drug discovery with our exclusive webinar featuring Dr. Thibault Géoui. Join Dr. Géoui as he guides you through the innovative integration of #AI with Logica’s cutting-edge data infrastructure and experimental validation processes. Learn about the real-world impact of AI on R&D efficiency, how Logica is setting new industry standards, and the significance of our risk-sharing model. Don’t miss this opportunity — watch the webinar recording now! https://okt.to/nYsPN5 #AI #drugdiscovery #pharmaceutical #Logica
-
Join this week’s webinar on #antibody-drug conjugates! Explore a full framework for ADC discovery and have your questions answered by industry experts. Register now: https://okt.to/GyBbcV
-
Logica is the logical alliance fueling transformation in small molecule drug discovery, bringing together wet science experience with industry-leading #AI technology to add certainty and speed to your program. Dive deeper into the benefits of partnering with Logica by visiting our website. https://okt.to/z0eK8k #AI #Logica #Drugdiscovery #LogicaAI #SmallMolecule
-
Discovery | Charles River reposted this
🔵 Drug Discovery & Development | One Step through to Drug Product Development | Tech Transfer | Academic Research | Company Creation | Biotech
Great to be here at the #DMDG Open Meeting in #York. Stop by our stand, meet our team at the University of York today to learn more about our ADME/DMPK capabilities. Gary Wilson | Discovery & Development Joseph Zolnerciks, Ph.D. | Discovery & Development Claire Purdy | DMPK/ADME Senior Scientist Stuart Robjohns | DMPK Group Leader Discovery | Charles River #drugdevelopment #biotech #therapeutics #drugdiscovery #oncology #immunology #neuroscience #antibody #ophthalmology #cardiovascular #respiratory #inflammation #pharmaceuticals #chemistry #biology #CharlesRiver #Lifesciences #startups #ADME #DMPK
-
How does early #biomarker research benefit both patients and drug developers? Listen to this episode with biomarker expert Stefan Kostense to find out: https://okt.to/0W2xbg